prostate cancer coalition of nc a statewide collaborative effort by concerned organizations and...
TRANSCRIPT
Prostate Cancer Coalition of NC
A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and “best practices” care for men who are,
or will someday be, prostate cancer survivors.
www.pccnc.org
Learning Objectives
1. Risk benefit discussion
2. Screening and prostate health
3. Early detection to support clinical treatment guidelines for patients that opt to screen
4. Tools to support informed pre-treatment consult for your patients
Risk Benefit Discussion
Risk Assessment Physical Exam & Baseline PSA Careful review of personal health and
family history A Thorough Understanding of the
Diagnostic and Decision Making Process
Risks
Screening can help identify, but is not specific to, prostate cancer.
65% of elevated PSA is caused by: other prostate health conditions activity known to artificially elevate PSA
Screening can be normal even when a man has prostate cancer.
Abnormal screening is NOT a cancer diagnosis. Every man diagnosed with prostate cancer should know to
consider personal health, priorities, and how aggressive his cancer is prior to evaluating treatment options.
Benefits
Can help identify several non-cancerous conditions. can become uncomfortable if left untreated
Only known method of detecting prostate cancer during its early stages.
Better options, and often more time to research and consider those options.
Evidence Based Healthcare
Johns Hopkins/ Cochrane Collaboration course, "Understanding evidence-based healthcare: A foundation for action."
PCP Clinical Practice Guidelines
Reflect NCCN guidelines applicable in a primary care setting
A convenient, evidence-based reference for evaluating screening results
Reviewed and supported by NC’s 3 National Cancer Institute (NCI)-designated Cancer Centers (Duke, UNC, and Wake Forest)
Referral Discussion Guide
Reflects American Urological Association “best practices” guidelines for follow up
Facilitates patient’s ongoing education and shared decision making
Newly Diagnosed Tutorial
Helps patient understand prognostic factors at diagnosis
Supports patient involvement and a multidisciplinary analysis of treatment options
Localized Pilot Program
Multi-disciplinary consultation encouraged and supported
Forms to support multi-institutional collaboration
Collaborate to Provide Leading Edge Research and the Best Possible Care for
those Affected by this Disease
Difficult cases discussed at local GU tumor board
When necessary, engage with academic centers
Moving Forward: Goals
Reduce the prostate cancer death rate
Continue to address gaps in patient education
Support personalized care Facilitate informed / shared decision
making
Conclusion: practical strategy
Avoid under-detection of aggressive/ potentially fatal cancers
Manage over-detection with the guidance of modern clinical treatment guidelines
Empower patients to be actively involved in treatment choice
Primary care physicians, urologists and oncologists work together